Trends & Forecasts

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

As the fires of the American opioid crisis continue to burn, can new painkillers step in?

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.